--- title: "CapsoVision (CV) stock listing, news and investor profile" url: "https://aibio.space/companies/capsovision/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "CapsoVision, Inc (NASDAQ: CV), United States. Listing facts, related biotech companies and news on aibio.space." --- CV CapsoVision, Inc NASDAQ · United States # CapsoVision (CV) news CapsoVision, Inc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest CapsoVision news We have not published a story on CapsoVision yet. When there is news, it will appear here. ## CapsoVision at a glance - **Ticker**: CV - **Listing**: NASDAQ - **Country**: United States ### Related companies - [BIOADAPTIVES, INC.](https://aibio.space/companies/bioadaptives/) OTC: BDPT - [CONMED](https://aibio.space/companies/conmed/) NYSE: CNMD - [Green Planet Bio Engineering Co.](https://aibio.space/companies/green-planet-bio-engineering/) OTC: GPLB - [Envoy Medical](https://aibio.space/companies/envoy-medical/) NASDAQ: COCH - [DarioHealth](https://aibio.space/companies/dariohealth/) NASDAQ: DRIO - [CareDx](https://aibio.space/companies/caredx/) NASDAQ: CDNA - [KESTRA MEDICAL TECHNOLOGIES, LTD.](https://aibio.space/companies/kestra-medical-technologies/) NASDAQ: KMTS - [ENvue Medical](https://aibio.space/companies/envue-medical/) OTC: FEED ### Also on NASDAQ - [REPLIGEN CORP](https://aibio.space/companies/repligen/) RGEN - [CAMP4 Therapeutics](https://aibio.space/companies/camp4-therapeutics/) CAMP - [Revelation Biosciences](https://aibio.space/companies/revelation-biosciences/) REVB - [Palvella Therapeutics](https://aibio.space/companies/palvella-therapeutics/) PVLA - [DEXCOM INC](https://aibio.space/companies/dexcom/) DXCM - [Pliant Therapeutics](https://aibio.space/companies/pliant-therapeutics/) PLRX ## CapsoVision annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$13.6 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | [$11.8 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | | Research and development | [$18.3 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | [$15.1 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | | Net income (loss) | [-$25.3 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | [-$19.9 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | | Cash from operations | [-$22.9 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | [-$20.1 million](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000010/) | Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about CapsoVision What is the ticker symbol of CapsoVision? CapsoVision, Inc trades under the ticker CV on NASDAQ. Where is CapsoVision listed? CapsoVision, Inc is listed on NASDAQ. Which country or territory is CapsoVision listed under? Our directory records CapsoVision, Inc under United States. Does aibio.space cover CapsoVision? aibio.space lists CapsoVision, Inc among 2,820 public biotech companies and publishes its news here as stories appear. What was CapsoVision's revenue last year? $13.6 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is CapsoVision profitable? CapsoVision, Inc reported a net loss of $25.3 million for the fiscal year ended Dec 31, 2025, and used $22.9 million of cash in operations, per its annual report to the SEC. How much does CapsoVision spend on research and development? $18.3 million in the fiscal year ended Dec 31, 2025, per its annual report. ## Investor discussion: CapsoVision Members talk about CapsoVision (CV). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at CapsoVision, newest first. Each line links the filing it comes from. 1. 2026-09-18 Financings Reported a financing. SEC Form 8-K (Items 1.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000043/cv-20260917.htm) 2. 2026-08-13 Financings Reported a financing. SEC Form 8-K (Items 1.01,2.02,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1378325/000137832526000035/cv-20260813xex991q22026ear.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:CV on TradingView](https://www.tradingview.com/symbols/NASDAQ-CV/). ## Listing details CapsoVision, Inc is a public biotech or pharmaceutical company listed on NASDAQ under the ticker CV, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: CapsoVision, Inc - **Ticker**: CV - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/capsovision/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "CapsoVision (CV) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/capsovision/